CoStim Pharmaceuticals' Acquisition

CoStim Pharmaceuticals was acquired by Novartis on February 17, 2014.

CoStim Pharmaceuticals is a biotechnology company focused on harnessing a patient's own immune system by blocking the suppressive signals from cancer that shut down the immune response. CoStim has lat…

Articles about CoStim Pharmaceuticals' Acquisition: